Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus.
Biofactors · 2018
Last updated 2026-05-28In mouse brain tissue, GLP-1 receptors were found on nerve endings that release glutamate and GABA, two key brain chemicals. When activated by the drug exendin-4 at doses between 1 and 100 nanomolar, these receptors increased the release of glutamate and GABA. The effect was blocked by a second drug, exendin-3, and prevented by another compound that stops a specific signaling pathway.
AI summary of the abstract below.
| Journal | Biofactors, 2018 |
|---|---|
| Citations | 38 |
| Relative citation ratio | 1.90 |
| NIH percentile | 72 |
| Molecules | — |
Abstract
Glucagon-like peptide-1 receptors (GLP-1Rs) have been shown to mediate cognitive-enhancing and neuroprotective effects in the central nervous system. However, little is known about their physiological roles on central neurotransmission, especially at the presynaptic level. Using purified synaptosomal preparations and immunofluorescence techniques, here we show for the first time that GLP-1Rs are localized on mouse cortical and hippocampal synaptic boutons, in particular on glutamatergic and GABAergic nerve terminals. Their activation by the selective agonist exendin-4 (1-100 nM) was able to increase the release of either [ H]d-aspartate or [ H]GABA. These effects were abolished by 10 nM of the selective GLP1-R antagonist exendin-3 (9-39) and were prevented by the selective adenylyl cyclase inhibitor 2',5'-dideoxyadenosine (10 µM), indicating the involvement of classic GLP-1Rs coupled to G protein stimulating cAMP synthesis. Our data demonstrate the existence and activity of presynaptic receptors for GLP-1 that could represent additional mechanisms by which this neurohormone exerts its effects in the CNS. © 2017 BioFactors, 44(2):148-157, 2018.
Verbatim abstract via PubMed 29265673 ↗